Ephedrine decreases vesicular monoamine transporter-2 function

Synapse

Volumn 65, Issue 5, 2011, Pages 449-451

  Ellis, Jonathan D ^a   German, Christopher L ^a   Birdsall, Elisabeth ^a   Hanson, Jarom E ^a   Crosby, Marcus A ^a   Rowley, Shane D ^a   Sawada, Nicole A ^a   West, Jeremiah N ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Dopamine; Fenfluramine; Methamphetamine; VMAT2

Indexed keywords

AMPHETAMINE; DOPAMINE; EPHEDRINE; FENFLURAMINE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; CORPUS STRIATUM; DOPAMINE UPTAKE; DOSE RESPONSE; HIPPOCAMPUS; HYPERTHERMIA; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPHEDRINE; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRITIUM; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 79952221452     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20896     Document Type: Article

References (15)

1. Bowyer JF, Newport GD, Slikker WJr., Gough B, Ferguson SA, Tor-Agbidye J. 2000. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. Toxicol Sci 55: 133-142.
2. Brown JM, Hanson GR, Fleckenstein AE. 2000. Methamphetamine rapidly decreases vesicular dopamine uptake. J Neurochem 74: 2221-2223.
3. Brown JM, Hanson GR, Fleckenstein AE. 2001. Cocaine-induced increases in vesicular dopamine uptake: Role of dopamine receptors. J Pharmacol Exp Ther 298: 1150-1153.
4. Brown JM, Riddle EL, Sandoval V, Weston RK, Hanson JE, Crosby MJ, Ugarte YV, Gibb JW, Hanson GR, Fleckenstein AE. 2002. A single methamphetamine administration rapidly decreases vesicular dopamine uptake. J Pharmacol Exp Ther 302: 497-501.
5. Brown JM, Yamamoto BK. 2003. Effects of amphetamines on mitochondrial function: Role of free radicals and oxidative stress. Pharmacol Ther 99: 45-53.
6. Chu PW, Seferian KS, Birdsall E, Truong JG, Riordan JA, Metcalf CS, Hanson GR, Fleckenstein AE. 2008. Differential regional effects of methamphetamine on dopamine transport. Eur J Pharmacol 590: 105-110.
7. Fleckenstein AE, Volz TJ, Hanson GR, 2009. Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications. Neuropharmacology 56: 133-138.
8. Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE. 2002. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: Mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther 300: 1093-1100.
9. Nash JF, Yamamoto BK. 1992. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3, 4-methylenedioxymethamphetamine. Brain Res 581: 237-243.
10. Peat MA, Warren PF, Gibb JW. 1983. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain. J Pharmacol Exp Ther 225: 126-131.
11. Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ, Adair BP, Bitter R, Gibb JW, Hanson GR, Fleckenstein AE. 2006. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake. J Pharmacol Exp Ther 318: 676-682.
12. Rothman RB, Vu N, Partilla JS, Roth BJ, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA. 2003. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307: 138-145.
13. Sandoval V, Riddle EL, Hanson GR, Fleckenstein AE. 2002. Methylphenidate redistributes vesicular monoamine transporter-2: Role of dopamine receptors. J Neurosci 22: 8705-8710.
14. Thomas DM, Francescutti-Verbeem DM, Kuhn DM. 2008. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 105: 605-616.
15. Yamamoto BK, Bankson MG. 2005. Amphetamine neurotoxicity: Cause and consequence of oxidative stress. Crit Rev Neurobiol 17: 87-117.